Inventor · disambiguated record
Marc R. Morra
Also filed as: MORRA MARC · MORRA MARC R
18 granted patents·4 pending applications·306 citations·filing 2005–2020
94Inventor score
Top patents by PatentIndex Score
22 records- 0197US9353176B2Method of treating osteoarthritis with an antibody to NGFREGENERON PHARMA·Filed 2013·Granted May 31, 2016·67 cites·13 claims
- 0297US8309088B2Method of treating osteoarthritis with an antibody to NGFMACDONALD LYNN·Filed 2010·Granted Nov 13, 2012·77 cites·14 claims
- 0396US8148107B2High affinity human antibodies to human nerve growth factorMACDONALD LYNN·Filed 2011·Granted Apr 3, 2012·52 cites·16 claims
- 0496US7988967B2High affinity human antibodies to human nerve growth factorREGENERON PHARMA·Filed 2008·Granted Aug 2, 2011·39 cites·17 claims
- 0593US8637031B2Method of treating osteoarthritis with an antibody to NGFREGENERON PHARMA·Filed 2012·Granted Jan 28, 2014·16 cites·11 claims
- 0693US8613927B2High affinity human antibodies to human nerve growth factorMACDONALD LYNN·Filed 2012·Granted Dec 24, 2013·20 cites·16 claims
- 0790US8425907B2Methods for treating pruritus by administering an antibody that specifically binds human PAR2MACDONALD LYNN·Filed 2011·Granted Apr 23, 2013·14 cites·6 claims
- 0887US10266588B2Method of treating osteoarthritis with an antibody to NGFREGENERON PHARMA·Filed 2016·Granted Apr 23, 2019·4 cites·29 claims
- 0987US8101724B2High-affinity human antibodies to human protease-activated receptor-2MACDONALD LYNN·Filed 2010·Granted Jan 24, 2012·10 cites·6 claims
- 1078US8088971B2Expression enhancing intron sequencesSONG HEE-SOOK·Filed 2006·Granted Jan 3, 2012·3 cites·20 claims
- 1175US10745471B2Method of treating osteoarthritis with an antibody to NGFREGENERON PHARMA·Filed 2019·Granted Aug 18, 2020·0 cites·18 claims
- 1275US8884098B2Expression cassettes for regulation of expression in monocotyledonous plantsSONG HEE-SOOK·Filed 2006·Granted Nov 11, 2014·2 cites·13 claims
- 1374US11518804B2Method of treating osteoarthritis with an antibody to NGFREGENERON PHARMA·Filed 2020·Granted Dec 6, 2022·0 cites·28 claims
- 1472US9371383B2Anti-ASIC1 antibodies and uses thereofREGENERON PHARMA·Filed 2013·Granted Jun 21, 2016·1 cites·16 claims
- 1571US9028819B2Methods of alleviating itch by administering human antibodies to human protease-activated receptor 2REGENERON PHARMA·Filed 2013·Granted May 12, 2015·1 cites·26 claims
- 1661US2014237683A1Expression enhancing intron sequencesBASF PLANT SCIENCE GMBH·Filed 2014·Application pending·0 cites
- 1759US10513557B2Anti-ASIC1 antibodies and uses thereofREGENERON PHARMA·Filed 2017·Granted Dec 24, 2019·0 cites·27 claims
- 1857US9150648B2Anti-ASIC1 antibodies and uses thereofREGENERON PHARMA·Filed 2013·Granted Oct 6, 2015·0 cites·19 claims
- 1956US8759506B2Expression enhancing intron sequencesSONG HEE-SOOK·Filed 2011·Granted Jun 24, 2014·0 cites·18 claims
- 2053US2015033409A1Expression cassettes for regulation of expression in monocotyledonous plantsBASF PLANT SCIENCE GMBH·Filed 2014·Application pending·0 cites
- 2147US2016002332A1Anti-ASIC1 Antibodies and Uses ThereofREGENERON PHARMA·Filed 2015·Application pending·0 cites
- 2235US2007174927A1Transgenic expression constructs for vegetative plant tissue specific expression of nucleic acidsBASF PLANT SCIENCE GMBH·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marc R. Morra files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →